Insilico on Applying AI to Transform Drug Discovery
Share
Insilico Medicine Founder & CEO Alex Zhavoronkov discusses how his company aims to apply artificial intelligence to revolutionize drug discovery and longevity research. He speaks with Haslinda Amin from the sidelines of 'JPMorgan Global China Summit' in Shanghai.